Financials

  • Market Capitalization 334.14 M
  • Employee 161
  • Founded 2018
  • CEO N/A
  • Website www.lyell.com
  • Headquarter Delaware, United States
  • FIGI BBG00RNXFN14
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.47
市销率
11.12 K

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3228
FATE
Fate Therapeutics, Inc. - Common Stock
2.98 USD-0.33%+1.71%+46.80%+161.40%347.35 M USD
3236
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.98 USD+13.31%+23.14%-21.37%+56.84%337.46 M USD
3244
IMRX
Immuneering Corporation - Class A Common Stock
5.18 USD-0.58%-6.33%+23.63%+27.59%335.13 M USD
3249
ZNTL
Zentalis Pharmaceuticals, Inc. - common stock
4.78 USD+0.21%-1.65%+27.13%+254.07%340.27 M USD

新闻